Results 171 to 180 of about 13,960 (212)

Exhaled nitric oxide in the assessment of asthma

Current Opinion in Pulmonary Medicine, 2004
Asthma is now defined as a TH2-mediated inflammatory disease involving both large and small airways. However, assessment of airways inflammation is limited by techniques that are time consuming and possibly distressing to the patient. Exhaled nitric oxide, an easily and rapidly obtained noninvasive study, is a potential surrogate for measuring airways ...
Michelle R, Zeidler, Eric C, Kleerup, Donald P, Tashkin   +2 more
openaire   +2 more sources

Exhaled nitric oxide in pediatric asthma

Current Allergy and Asthma Reports, 2008
Exhaled nitric oxide can now be measured in a clinical setting as a noninvasive, reproducible, facile, point-of-service test to measure airway inflammation, a central component of asthma that had not been assessed previously. An excellent surrogate marker of steroid-responsive eosinophilic airway inflammation, it serves to identify steroid-sensitive ...
openaire   +2 more sources

Determinants of Exhaled Nitric Oxide in Chronic Rhinosinusitis

Chest, 2010
Chronic rhinosinusitis (CRS) has been reported to be associated with increased values of exhaled nitric oxide (ENO), which could not be entirely explained by the association between CRS and asthma. The aim of this study was to investigate the variables associated with increased ENO in patients with CRS.This was a prospective cross-sectional descriptive
Giuseppe, Guida, Giovanni, Rolla, Iuliana, Badiu, Pietro, Marsico, Stefano, Pizzimenti, Luisa, Bommarito, Antonella, De Stefani, Antonio, Usai, Massimiliano, Bugiani, Andrei, Malinovschi, Caterina, Bucca, Enrico, Heffler   +11 more
openaire   +2 more sources

Fraction of Nitric Oxide in Exhaled Breath

Clinics in Chest Medicine
Nitric oxide (NO) is an odorless gaseous molecule important for biological functions including regulation of vasodilation, smooth muscle relaxation, neurotransmission, platelet aggregation inhibition, and airway epithelial barrier function. It was first discovered in exhaled breath by Gustafsson and colleagues in 1991.
Amisha, Barochia, Loretta G, Que
openaire   +2 more sources

[Exhaled nitric oxide as a marker of diseases].

Recenti progressi in medicina, 2005
Recently a method to measure nitric oxide (NO) concentration in exhaled air has been developed. The method is non-invasive and easy to perform and it provides information on a fascinating molecule, with such extensive respiratory functions, ranging from bronchial and vascular dilation to ciliary motion and antibacterial defense.
ROLLA G, HEFFLER, ENRICO MARCO, BOMMARITO L, BERGIA R, FERRERO N.   +4 more
openaire   +2 more sources

Exhaled nitric oxide and wheezing phenotypes

Pediatric Pulmonology, 2013
Caudri, Daan, Valk, Ralf, Jongste, Johan, Smit, HA   +3 more
openaire   +3 more sources

Exhaled Nitric Oxide

Immunology and Allergy Clinics of North America, 2018
Flavia C.L. Hoyte, Lara M. Gross, Rohit K. Katial   +2 more
openaire   +1 more source

Exhaled nitric oxide

Journal of Allergy and Clinical Immunology, 2003
Donald Y.M Leung, Harold S Nelson, Stanley J Szefler, William W Busse   +3 more
openaire   +1 more source

Exhaled Nitric Oxide: An Update.

Immunology and allergy clinics of North America, 2019
Fractional concentration of exhaled nitric oxide (FENO) is a biomarker used to identify allergic airway inflammation. Because it is noninvasive and easy to obtain, its utility has been studied in the diagnosis and management of several respiratory diseases. Much of the research has been done in asthma, and many studies support the use of FENO in aiding
Flavia C L, Hoyte, Lara M, Gross, Rohit K, Katial   +2 more
openaire   +1 more source

Exhaled Nitric Oxide

Respiratory Care, 1999
Marlene Gerlach, Herwig Gerlach
openaire   +1 more source